FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Enhertu Approval Broadens Breast Cancer Use

FDA approves AstraZeneca and Daiichi Sankyos Enhertu (trastuzumab deruxtecan) for treating adult patients with unresectable or metastatic hormone rece...

latest-news-card-1
Human Drugs

No Informed Consent at Trial Site: FDA

FDA warns the Miami Dade Medical Research Institute and Dr. Americo Padilla about failing to obtain proper informed consent for pediatric patients in ...

latest-news-card-1
Biologics

2 Firms Illegally Selling Biologics: FDA

FDA warns New York, NY-based Evolutionary Biologics and Chatsworth, CA-based Chara Biologics about illegally manufacturing and distributing unapproved...

latest-news-card-1
Human Drugs

FDA Priority Review for New Merck Welireg Indication

FDA sets 5/25 for its decision on a new indication for Mercks Welireg to treat patients with advanced pheochromocytoma and paraganglioma.

latest-news-card-1
Medical Devices

AI Optics Handheld Retinal Imager Cleared

FDA clears an AI Optics 510(k) for its Sentinel Camera, a handheld retinal imaging device for capturing images of the human eye.

latest-news-card-1

TerSera Wants Prialt ANDA Conditions

TerSera petitions FDA to require any ANDA referencing Prialt to conduct compatibility testing with the Medtronic pump that is specified in Prialts lab...

latest-news-card-1
FDA General

RFK Jr.s Cousin Trashes Him on Eve of Hearing

Robert F. Kennedy Jr.s cousin, Caroline Kennedy, sends a scathing letter about his background to U.S. senators on the eve of a confirmation hearing to...

latest-news-card-1
Human Drugs

Provepharm Recalls Phenylephrine HCl

Provepharm recalls one lot of phenylephrine hydrochloride injection, USP, 10 mg/mL due to a customer complaint about visible black particulate matter ...

latest-news-card-1
Human Drugs

Once Monthly Leqembi for Alzheimers Approved

FDA approves an Eisai/Biogen supplemental BLA for Leqembi (lecanemab-irmb) and its intravenous use once every four weeks as maintenance dosing in Alzh...

latest-news-card-1
Human Drugs

Pfizer Pays $60 million to Settle Biohaven Kickbacks

Pfizer agrees to pay $59.7 million to resolve allegations that its subsidiary, Biohaven Pharmaceutical, engaged in previous illegal kickback schemes.